Skip to main content
Rami Khoriaty, MD, Oncology, Ann Arbor, MI

Rami Naim Khoriaty MD

Hematologic Oncology


Physician

Join to View Full Profile
  • 1500 E Medical Center DrB1 Floor Cancer Recp BAnn Arbor, MI 48109

  • Phone+1 734-936-6000

Dr. Khoriaty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2006 - 2009
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 2005

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2009 - 2028
  • OH State Medical License
    OH State Medical License 2006 - 2009
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Journal Articles

  • Functions of the COPII Gene Paralogs SEC23A and SEC23B Are Interchangeable in Vivo  
    Rami Khoriaty, Lesley Everett, Jordan A Shavit, Angela C Weyand, David Ginsburg, Proceedings of the National Academy of Sciences

Abstracts/Posters

  • Functional Overlap between the SEC23 Paralogs Suggests a Novel Treatment Paradigm for Congenital Dyserythropoietic Anemia Type II
    Rami Khoriaty, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Key Pathway for Activated T-cells Might Be Targeted to Fight GVHD
    Key Pathway for Activated T-cells Might Be Targeted to Fight GVHDJanuary 21st, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: